Variant report
Variant | nsv470824 |
---|---|
Chromosome Location | chr6:66214008-66254084 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs724103 | chr6:66234241-66234242 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs724104 | chr6:66234247-66234248 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs533910547 | chr6:66234272-66234273 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs374453809 | chr6:66234296-66234297 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs185433496 | chr6:66234307-66234308 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs144891015 | chr6:66234347-66234348 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs536941869 | chr6:66234432-66234433 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs556942813 | chr6:66234435-66234436 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs148512562 | chr6:66234489-66234490 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs182822561 | chr6:66234526-66234527 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs138641777 | chr6:66234625-66234626 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs9363384 | chr6:66234737-66234738 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
13 | rs372842749 | chr6:66234807-66234808 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs9354260 | chr6:66234821-66234822 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
15 | rs544064055 | chr6:66234843-66234844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs141769234 | chr6:66234894-66234895 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs35986893 | chr6:66234948-66234949 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs386407366 | chr6:66234955-66234956 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs200412074 | chr6:66234961-66234962 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs566553512 | chr6:66234983-66234984 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs185943875 | chr6:66235036-66235037 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs370849404 | chr6:66235061-66235062 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs558838357 | chr6:66235072-66235073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs577082771 | chr6:66235080-66235081 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs571600972 | chr6:66235086-66235087 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs534307956 | chr6:66235120-66235121 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs115144168 | chr6:66235137-66235138 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs556760663 | chr6:66235196-66235197 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs567647040 | chr6:66235204-66235205 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs9363385 | chr6:66235215-66235216 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs556879487 | chr6:66235258-66235259 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs75471217 | chr6:66235266-66235267 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs9453319 | chr6:66235307-66235308 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs371168799 | chr6:66235339-66235340 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs75940045 | chr6:66235344-66235345 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs577627969 | chr6:66235388-66235389 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs9354261 | chr6:66235479-66235480 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs191595207 | chr6:66235507-66235508 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs573562252 | chr6:66235529-66235530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs183944519 | chr6:66235530-66235531 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs562413100 | chr6:66235562-66235563 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs188838367 | chr6:66235636-66235637 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs193288034 | chr6:66235678-66235679 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs565080641 | chr6:66235682-66235683 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs540197154 | chr6:66235738-66235739 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs73447233 | chr6:66235752-66235753 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs557337131 | chr6:66238902-66238903 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs568621141 | chr6:66238908-66238909 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs570530022 | chr6:66238935-66238936 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs117358421 | chr6:66238967-66238968 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 16573809 | CNVD |
Ovarian cancer | 19835627 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Dyslexia | 22102821 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 20164919 | CNVD |
Retinitis pigmentosa | 21519034 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:66234200-66234600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr6:66234600-66235000 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr6:66235000-66235800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr6:66238800-66239800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr6:66241000-66242600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
6 | chr6:66242600-66245600 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
7 | chr6:66245600-66246000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
8 | chr6:66245600-66246000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
9 | chr6:66245600-66246600 | Enhancers | Primary hematopoietic stem cells | blood |
10 | chr6:66247400-66248000 | Enhancers | Fetal Brain Male | brain |
11 | chr6:66248400-66248800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |